Ongoing investigations into cretostimogene are expanding across multiple patient populations and therapeutic strategies, building a robust and diverse clinical portfolio. Current studies include ...

The investigators found a clear, dose-response relationship between patient-reported incontinence severity and the subsequent use of incontinence interventions such as artificial sphincters or bulking ...

Key Takeaways Expert panel developed guidelines for onabotulinumtoxinA use in OAB, emphasizing patient experience and compliance. Recommendations cover patient counseling, pre-procedure urinalysis, ...

Key Takeaways Technological advancements in sacral neuromodulation include MRI-conditional devices, rechargeable systems, and extended battery lifespans, enhancing patient eligibility and reducing ...

Panelists discuss emerging immunotherapy strategies for BCG-unresponsive non–muscle-invasive bladder cancer (NMIBC), particularly the combination of BCG with systemic checkpoint inhibitors, noting ...

In a recent interview with Urology Times ®, David Stanley, MD, FACS, discussed current trends and unmet needs in the treatment of patients with kidney stones. Stanley is a urologic surgeon at Georgia ...

In a groundbreaking cross-border collaboration, Cleveland Clinic urologists recently completed the world's first remotely performed robot-assisted high-intensity focused ultrasound (HIFU) focal ...

Lymph Node Management and Molecular Imaging Main Discussion Topics: The current approach typically limits lymph node dissection to radiographically evident disease. Molecular imaging could identify ...

The final results of the BOND-3 trial, recently presented at major urology conferences, have reinforced the promise of intravesical cretostimogene as a treatment for patients with BCG-unresponsive CIS ...

There has been an explosion in innovation in the non–muscle invasive bladder cancer (NMIBC) space over the past few years. In an interview with Urology Times ®, Anne K. Schuckman, MD, detailed the ...

Complex Renal Masses and Molecular Imaging Main Discussion Topics: Challenges of managing anatomically complex renal masses Potential for molecular imaging to influence nephron-sparing decisions ...

Key Takeaways Apalutamide showed a significant survival advantage over abiraterone and enzalutamide in mCSPC, with a 26% and 23% reduction in mortality risk, respectively. Real-world data are ...